IOL CHEMICALS & PHARM. | AJANTA PHARMA | IOL CHEMICALS & PHARM./ AJANTA PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 36.6 | 37.3% | View Chart |
P/BV | x | 1.6 | 7.9 | 19.6% | View Chart |
Dividend Yield | % | 1.0 | 0.3 | 306.1% |
IOL CHEMICALS & PHARM. AJANTA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
AJANTA PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ AJANTA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 1,426 | 37.6% | |
Low | Rs | 272 | 1,062 | 25.6% | |
Sales per share (Unadj.) | Rs | 377.6 | 297.2 | 127.0% | |
Earnings per share (Unadj.) | Rs | 23.7 | 46.7 | 50.8% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 57.1 | 55.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 7.00 | 57.1% | |
Avg Dividend yield | % | 1.0 | 0.6 | 175.8% | |
Book value per share (Unadj.) | Rs | 256.8 | 269.1 | 95.4% | |
Shares outstanding (eoy) | m | 58.71 | 125.91 | 46.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 4.2 | 25.6% | |
Avg P/E ratio | x | 17.1 | 26.6 | 64.1% | |
P/CF ratio (eoy) | x | 12.8 | 21.8 | 58.8% | |
Price / Book Value ratio | x | 1.6 | 4.6 | 34.1% | |
Dividend payout | % | 16.9 | 15.0 | 112.6% | |
Avg Mkt Cap | Rs m | 23,743 | 156,638 | 15.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 7,851 | 21.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 37,426 | 59.2% | |
Other income | Rs m | 256 | 986 | 26.0% | |
Total revenues | Rs m | 22,427 | 38,413 | 58.4% | |
Gross profit | Rs m | 2,257 | 7,833 | 28.8% | |
Depreciation | Rs m | 462 | 1,308 | 35.3% | |
Interest | Rs m | 165 | 58 | 282.0% | |
Profit before tax | Rs m | 1,887 | 7,453 | 25.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 1,573 | 31.5% | |
Profit after tax | Rs m | 1,391 | 5,880 | 23.7% | |
Gross profit margin | % | 10.2 | 20.9 | 48.6% | |
Effective tax rate | % | 26.2 | 21.1 | 124.4% | |
Net profit margin | % | 6.3 | 15.7 | 39.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 28,252 | 34.2% | |
Current liabilities | Rs m | 5,025 | 11,393 | 44.1% | |
Net working cap to sales | % | 20.9 | 45.0 | 46.5% | |
Current ratio | x | 1.9 | 2.5 | 77.6% | |
Inventory Days | Days | 43 | 66 | 65.7% | |
Debtors Days | Days | 8 | 10 | 80.7% | |
Net fixed assets | Rs m | 11,017 | 18,707 | 58.9% | |
Share capital | Rs m | 587 | 253 | 232.3% | |
"Free" reserves | Rs m | 14,490 | 33,624 | 43.1% | |
Net worth | Rs m | 15,077 | 33,877 | 44.5% | |
Long term debt | Rs m | 0 | 13 | 0.0% | |
Total assets | Rs m | 20,684 | 47,047 | 44.0% | |
Interest coverage | x | 12.5 | 128.6 | 9.7% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.8 | 134.7% | |
Return on assets | % | 7.5 | 12.6 | 59.6% | |
Return on equity | % | 9.2 | 17.4 | 53.2% | |
Return on capital | % | 13.6 | 22.2 | 61.4% | |
Exports to sales | % | 26.7 | 59.9 | 44.6% | |
Imports to sales | % | 0 | 11.5 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 22,420 | 26.4% | |
Imports (cif) | Rs m | NA | 4,293 | 0.0% | |
Fx inflow | Rs m | 5,930 | 22,420 | 26.4% | |
Fx outflow | Rs m | 6,052 | 4,293 | 141.0% | |
Net fx | Rs m | -122 | 18,127 | -0.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 7,918 | 15.4% | |
From Investments | Rs m | -1,200 | -5,596 | 21.4% | |
From Financial Activity | Rs m | -41 | -1,079 | 3.8% | |
Net Cashflow | Rs m | -18 | 1,243 | -1.5% |
Indian Promoters | % | 48.2 | 66.2 | 72.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 26.0 | 6.5% | |
FIIs | % | 1.4 | 8.5 | 16.4% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 33.8 | 153.3% | |
Shareholders | 130,003 | 55,488 | 234.3% | ||
Pledged promoter(s) holding | % | 0.0 | 12.3 | - |
Compare IOL CHEMICALS & PHARM. With: CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | AJANTA PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.56% | 0.30% | 0.97% |
1-Month | 5.64% | -3.67% | 2.08% |
1-Year | -1.14% | 65.99% | 55.37% |
3-Year CAGR | -12.91% | 21.22% | 15.04% |
5-Year CAGR | 16.34% | 25.46% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the AJANTA PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of AJANTA PHARMA the stake stands at 66.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of AJANTA PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
AJANTA PHARMA paid Rs 7.0, and its dividend payout ratio stood at 15.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of AJANTA PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.